Skip to main content

Worldwide Smart Pills Market Analysis & Forecast (2018-2025) by Application, Target Area, Disease Indication and End-User - ResearchAndMarkets.com

The "Smart Pills Market by Application, Target Area, Disease Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global smart pills market was valued at $257 million in 2017, and is projected to reach $650 million by 2025, growing at a CAGR of 12.1% from 2018 to 2025.

A significant rise in geriatric population, rise in chronic disorders such as cancer, diabetes, and others, drive the smart pills market growth. In addition, increased R&D investments by manufacturers in developing smart pills boosts the market growth.

However, stringent governmental regulations regarding the vigorous use of these devices and high cost associated with the ingestible sensors is anticipated to restrain the market growth. On the contrary, surge in technological advances in bioelectronics, and availability of microprocessors are anticipated to offer lucrative opportunities in the future.

Select Findings

  • The small intestine segment, by target area dominated the smart pills market in 2017 and is expected to maintain this trend during the forecast period.
  • The colon disease segment, by disease indication, is expected to register highest CAGR of 13.6% from 2018-2025.
  • U.S. generated the highest revenue in the global smart pills market in 2017 accounting for more than half of the market in North America.
  • Asia-Pacific is the fastest growing region in the smart pills market in 2017 and is anticipated to experience rapid growth during the forecast period.

Key Players

  • Proteus Digital Health
  • HQ
  • CapsoVision
  • Medtronic
  • Olympus Corporations
  • IntroMedic Co.
  • RF Co.
  • JINSHAN Science & Technology
  • Check Cap
  • Koninklijke Philips

Other Players

  • GE Healthcare
  • Novartis
  • Fujifilm Holdings Corporation
  • Bio-Images Drug Delivery (BDD) Limited
  • Quotient Clinical
  • Innovative Devices
  • PENTAX Medical

Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Smart Pills Market, by Application

Chapter 5: Smart Pills Market, by Target Area

Chapter 6: Smart Pills Market, by Disease Indication

Chapter 7: Smart Pills Market, by End-User

Chapter 8: Smart Pills Market, by Region

Chapter 9: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/bkgx8c/worldwide_smart?w=4

Contacts:

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Drug Delivery

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.